Condition: Atrial Fibrillation · Sponsor: Medtronic Cardiac Ablation Solutions
PULSED AF PAS is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months.
This description comes directly from the study's public registry record.
Josman Suri · 7635050262 · josman.suri@medtronic.com
Always discuss trial participation with your own doctor first.
| University of South Florida Health (USF) | Tampa, Florida, United States | Recruiting |
| Piedmont Heart Institute | Atlanta, Georgia, United States | Recruiting |
| Endeavor Health Swedish Hospital | Chicago, Illinois, United States | Recruiting |
| Pikeville Medical Center | Whitesburg, Kentucky, United States | Recruiting |
| Southcoast Health System | Fall River, Massachusetts, United States | Recruiting |
| Beaumont Health System | Royal Oak, Michigan, United States | Withdrawn |
| Nebraska Medical Center | Omaha, Nebraska, United States | Recruiting |
| The Valley Hospital | New York, New York, United States | Recruiting |
| Northwell Health Lenox Hill Hospital | New York, New York, United States | Recruiting |
| Duke University Medical Center (DUMC) | Durham, North Carolina, United States | Recruiting |
| Bethesda North Hospital | Cincinnati, Ohio, United States | Recruiting |
| The Ohio State University Wexner Medical Center | Columbus, Ohio, United States | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06578104